Elevated allogeneic cytotoxic T lymphocyte activity in peripheral blood leukocytes of homosexual men.

Important note: Information in this article was accurate in 1986. The state of the art may have changed since the publication date.

Elevated allogeneic cytotoxic T lymphocyte activity in peripheral blood leukocytes of homosexual men.

J Immunol. 1985 Nov;135(5):3163-71. Unique Identifier : AIDSLINE MED/86009601
Tung KS; Koster F; Bernstein DC; Kriebel PW; Payne SM; Shearer GM

Abstract: Peripheral blood leukocytes (PBL) from male homosexual and heterosexual volunteers who did not have evidence of acquired immunodeficiency syndrome (AIDS) were studied for their ability to generate cytotoxic T lymphocyte (CTL) responses in vitro to allogeneic stimulator PBL from a single individual or from a pool of donors (allo-pool). Seventeen of 39 homosexual donors generated strong primary CTL activity to a single randomly selected stimulator donor, whereas only two of 16 heterosexual donors generated a strong CTL response to the same stimulators. A more detailed study was performed by using PBL from 11 of the homosexual and five of the heterosexual donors, in which CTL responses to the allo-pool were repeatedly tested over a 14-mo period. The response status of the donors that were strong and weak or moderate responders did not change during this period. No correlation of strength of CTL activity was observed with the following: HLA mismatching between responder and stimulator; proportion of OKT4+ and OKT8+ subsets in peripheral blood; antibodies to HTLV-III; antibody titers to hepatitis B, Epstein Barr virus, cytomegalovirus, or HLA alloantigens; homosexual practices; or circulating immune complex levels, although a statistical correlation by multivariate analysis was observed between elevated allogeneic CTL and a combination of other factors. The findings are discussed with respect to possible relevance to AIDS susceptibility and development.

Keywords: Adult Antibodies, Viral/ANALYSIS Antigens, Viral/ANALYSIS Comparative Study *Cytotoxicity Tests, Immunologic/METHODS *Cytotoxicity, Immunologic Histocompatibility Testing *Homosexuality Human Isoantigens/IMMUNOLOGY Leukocyte Count Life Style Lymphocyte Transformation Male Phenotype Support, Non-U.S. Gov't T-Lymphocytes, Cytotoxic/*IMMUNOLOGY JOURNAL ARTICLE

860130
M8610119

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1986. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1986. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .